BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20888200)

  • 1. Assessing extracranial tumors using diffusion-weighted whole-body MRI.
    Lenz C; Klarhöfer M; Scheffler K; Winter L; Sommer G
    Z Med Phys; 2011 May; 21(2):79-90. PubMed ID: 20888200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body diffusion-weighted magnetic resonance imaging.
    Kwee TC; Takahara T; Ochiai R; Katahira K; Van Cauteren M; Imai Y; Nievelstein RA; Luijten PR
    Eur J Radiol; 2009 Jun; 70(3):409-17. PubMed ID: 19403255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor search with diffusion-weighted imaging--first experience].
    Bohlscheid A; Nuss D; Lieser S; Busch HP
    Rofo; 2008 Apr; 180(4):302-9. PubMed ID: 18370348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary study on the validity of whole body diffusion-weighted imaging for the detection of malignant lesions].
    Wang JW; Zhao S; Liu Y; Li J; Xu LM
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):304-8. PubMed ID: 20510086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion-weighted magnetic resonance imaging and its application to cancer.
    Charles-Edwards EM; deSouza NM
    Cancer Imaging; 2006 Sep; 6(1):135-43. PubMed ID: 17015238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted MRI in the body: applications and challenges in oncology.
    Koh DM; Collins DJ
    AJR Am J Roentgenol; 2007 Jun; 188(6):1622-35. PubMed ID: 17515386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display.
    Takahara T; Imai Y; Yamashita T; Yasuda S; Nasu S; Van Cauteren M
    Radiat Med; 2004; 22(4):275-82. PubMed ID: 15468951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuously moving table MRI in oncology.
    Schaefer AO; Langer M; Baumann T
    Rofo; 2010 Nov; 182(11):954-64. PubMed ID: 20922644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
    Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted whole-body MR screening.
    Vilanova JC; Barceló J
    Eur J Radiol; 2008 Sep; 67(3):440-7. PubMed ID: 18430538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy.
    Low RN
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):245-61. PubMed ID: 19406357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography.
    Kwee TC; van Ufford HM; Beek FJ; Takahara T; Uiterwaal CS; Bierings MB; Ludwig I; Fijnheer R; Nievelstein RA
    Invest Radiol; 2009 Oct; 44(10):683-90. PubMed ID: 19724232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E; Bolacchi F; Altobelli S; Franceschini L; Bergamini A; Cantonetti M; Simonetti G
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
    Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
    J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body diffusion-weighted imaging: technical improvement and preliminary results.
    Li S; Sun F; Jin ZY; Xue HD; Li ML
    J Magn Reson Imaging; 2007 Oct; 26(4):1139-44. PubMed ID: 17896396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low b-value diffusion-weighted imaging: emerging applications in the body.
    Takahara T; Kwee TC
    J Magn Reson Imaging; 2012 Jun; 35(6):1266-73. PubMed ID: 22359279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Whole-body diffusion-weighted magnetic resonance imaging in oncology].
    Jouvet JC; Thomson V; Durupt F; Bakir M; Berthezene Y
    Presse Med; 2010 May; 39(5):548-52. PubMed ID: 19932000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study: diffusion weighted whole body imaging with background body signal suppression and hybrid Positron Emission Computed Tomography on detecting lesions in oncologic clinics.
    Wang N; Zhang M; Sun T; Chen H; Huang Z; Yan L; Wang L; Li F; Chen Z
    Eur J Radiol; 2012 Jul; 81(7):1662-6. PubMed ID: 21477959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.